Biotech Business Week

Finance - Record product sales and profitability reported by dermatology drug firm

Finance - Record third quarter achieved as neuro product sales increase 78%

Finance - Revenue increases 117% for cancer drug maker

Finance - Taxus maker reports 21% increase in sales

Finance - Therapeutic antibodies company reports net loss of $0.50 per share

Finances - Diagnostics testing provider announces net income of $120M for third quarter

Gene Expression - Data on new class of bacterial RNA polymerase inhibitor published

Glucose Therapy - FDA approvable letter issued for Fortamet

Gynecology - Phase I-IIa interim data of ovarian cancer treatment released

HIV Infection Treatment - FDA grants marketing clearance for Lexiva

HIV Therapy - New drug candidate disrupts virus life cycle in study

Health Information Management - FDA endorses CDISC standards development

Heart Defects - Mini-incisions mean less pain, scarring, less infection, faster recovery

Heart, Kidney Transplantation - FDA issues approvable letter for Certican

Hemophilia A - Advate receives unanimous positive opinion for marketing in Europe

Hepatitis - LabCorp partnership to offer liver-fibrosis assay

Hepatitis C - Response to standard Hepatitis C treatment predicted as early as week 1

Hernia Repair - ON-Q pain relief system helps patients return to their normal lives faster

Imaging - Cone Health inks radiology image and information management systems agreement

Immunostimulatory Agonists - $5.9M research grant from NIH to be used for bioterror defense

Information Technology - GeneChip technology selected for next phase of Human Genome Project

Insulin - Flamel clears antitrust requirement for Basulin licensing deal

License Agreement - Array manufacturer forges license agreement with Affymetrix

Liver Function - FDA 510(k) clearance granted for Aspartate Aminotransferase test

Lung Cancer - Lung cancer patients show 50% reduction in tumor size in phase II study

Market Analysis - Blockbuster drugs to lose market share over next decade

Market Analysis - Complex protein interaction webs challenge growth of functional proteomics

Market Analysis - Cosmetic surgery satisfaction declines with time

Market Research - Drug delivery technologies leading growth in $33B U.S. market

Marketing Opportunities - Study identifies low incidence medical conditions with high potential

Mergers and Acquisitions - Aralast acquired from Alpha Therapeutic

Mergers and Acquisitions - Cedra's in vitro drug metabolism business acquired

Mergers and Acquisitions - Complient acquired by cardiology company

Mergers and Acquisitions - Corporation executes letter of intent with German medical laboratory

Mergers and Acquisitions - IdeaSphere to complete acquisition of supplement maker

Mergers and Acquisitions - Merck's ownership in Japanese pharma reaches 99%

Mergers and Acquisitions - New pharmaceutical company opens and is primed for acquisitions

Monoclonal Antibodies - NIAID funding granted for new biodefence project

Narcolepsy - Approvable letter issued to broaden Provigil label

Obesity Epidemic - Study implicates obesity as major killer

Obstructive Lung Disease - Foradil Certihaler receives approvable letter from FDA

Parkinson Disease - Once-daily therapy reduces "off" time in Parkinson disease study patients

Particle Therapy - Companies partner to develop particle therapy solutions

Personnel - AIDS virus co-discoverer joins board of AIDS medical device company

Personnel - Biologicals developer names president and CEO

Personnel - Biotechnology visionary joins life sciences product development firm

Personnel - Brandt named VP of business development at pharmaceutical company

Personnel - Drug development company establishes scientific advisory board

Personnel - Ellis named president, CEO at biotech company

Personnel - Medical director appointed to management team at device firm

Personnel - Pharmaceutical company adds new members to board

Personnel - Scientific advisory board members named at oncology company

Personnel - Stern named senior VP, drug development at pharmaceutical firm

Personnel - Talpaz joins scientific advisory board at oncology firm

Personnel - Wound care company appoints new CIO

Pneumonia - Response submitted to FDA letter for Ketek

Product Commercialization - HemoCleanse announces the spin-out of subsidiary

Pulmonary Disease - Potential treatment studied for patients with wasting associated with COPD

RNA Interference - Milestone achieved in simultaneously disabling multiple genes

Rankings - Company recognized for fourth year in Technology Fast 50 rankings

Rankings - Schering-Plough named among top biotech and pharmaceutical employers

Rankings - Top biotech and pharmaceutical employers named

Regulation - Tissue processing company to respond to FDA inspection observation

Research Collaboration - Biopharmaceutical company enters research collaboration

Rheumatoid Arthritis - Blood and genetic sample bank available for rheumatoid arthritis research

Rheumatoid Arthritis - Phase II clinical trial of AGIX-4207 initiated

Rheumatoid Arthritis - Rheumatoid arthritis target triggers release of damaging inflammatory chemical

Services Agreements - Biotechnology company enters services and biotech access agreements

Sexual Dysfunction - Positive results presented from phase II trial of LibiGel

Sleep Deprivation - New drug improves performance in sleep-deprived study subjects

Social Anxiety Disorder - Depression treatment approved to treat social anxiety disorder

Soft Tissue Curettage - FDA approval letter issued for laser use in periodontal procedures

Spinal Disease - Coblation device introduced for new spinal application

Thrombosis - Curacyte awarded grant to fund development of factor Xa inhibitors

Type 2 Diabetes - Combination drug approved to treat special cases of type 2 diabetes